Literature DB >> 22309891

Sequential array comparative genomic hybridization analysis identifies copy number changes during blastic transformation of chronic myeloid leukemia.

Seung-Tae Lee1, Yongick Ji, Hee-Jin Kim, Chang-Seok Ki, Chul Won Jung, Jong-Won Kim, Sun-Hee Kim.   

Abstract

The present study was performed to provide direct evidence on copy number changes during progression from chronic phase (CP) to blastic phase (BP) in chronic myeloid leukemia (CML) through a longitudinal follow-up study. Matched CP and BP samples in three patients were analyzed using high-resolution array comparative genomic hybridization (aCGH) chips. During blastic transformation, loss of large genomic segments including 6q14.1-q22.31, chromosome 7 and 9p13.2-p21.3 were noted. Furthermore, small-sized copy number changes involving cancer-associated genes were observed. In addition, we identified a novel fusion gene consisted of PAX5 and MLLT3 (AF9). It is likely that blastic transformation of CML is a multi-step process associated accumulation of several genomic events which may largely overlap with those found in acute leukemias.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309891     DOI: 10.1016/j.leukres.2011.12.021

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

Review 1.  Genetic events other than BCR-ABL1.

Authors:  Paolo Neviani
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

2.  Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia.

Authors:  Grazia Fazio; Giulia Daniele; Valeria Cazzaniga; Luciana Impera; Marco Severgnini; Ilaria Iacobucci; Marta Galbiati; Anna Leszl; Ingrid Cifola; Gianluca De Bellis; Paola Bresciani; Giovanni Martinelli; Giuseppe Basso; Andrea Biondi; Clelia Tiziana Storlazzi; Giovanni Cazzaniga
Journal:  Haematologica       Date:  2014-10-10       Impact factor: 9.941

3.  PAX5 fusion genes in t(7;9)(q11.2;p13) leukemia: a case report and review of the literature.

Authors:  Dagmar Denk; Jutta Bradtke; Margit König; Sabine Strehl
Journal:  Mol Cytogenet       Date:  2014-02-07       Impact factor: 2.009

4.  CD5 molecule-like and transthyretin as putative biomarkers of chronic myeloid leukemia - an insight from the proteomic analysis of human plasma.

Authors:  Iram Fatima; Saima Sadaf; Syed Ghulam Musharraf; Naghma Hashmi; Muhammad Waheed Akhtar
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

Review 5.  Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update.

Authors:  Luana Bavaro; Margherita Martelli; Michele Cavo; Simona Soverini
Journal:  Int J Mol Sci       Date:  2019-12-05       Impact factor: 5.923

6.  DNA Fingerprint Analysis of Raman Spectra Captures Global Genomic Alterations in Imatinib-Resistant Chronic Myeloid Leukemia: A Potential Single Assay for Screening Imatinib Resistance.

Authors:  Rahul Mojidra; Arti Hole; Keita Iwasaki; Hemanth Noothalapati; Tatsuyuki Yamamoto; Murali Krishna C; Rukmini Govekar
Journal:  Cells       Date:  2021-09-22       Impact factor: 6.600

7.  PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Stefanie Anderl; Margit König; Andishe Attarbaschi; Sabine Strehl
Journal:  Mol Cytogenet       Date:  2015-07-08       Impact factor: 2.009

Review 8.  Understanding and Monitoring Chronic Myeloid Leukemia Blast Crisis: How to Better Manage Patients.

Authors:  Lulu Wang; Li Li; Rongrong Chen; Xianbo Huang; Xiujin Ye
Journal:  Cancer Manag Res       Date:  2021-06-23       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.